EUVIMED · CrossrefJournal
Journal of Clinical Apheresis
ISSN 0733-2459 · Wiley
Latest articles
Letter to the Editor on “A Personalized, Rate‐of‐Rise ( ROR )‐Driven Model to Optimize Red Cell Exchange Interval in Chronic Sickle Cell Management”
Individualizing Apheresis Processing Volumes Using a Predictive Algorithm: Analysis of the CAR T‐Cell Collection Protocol Utilized in ACIT001 / EXC002 , a Phase Ib/ II Trial of Decentralized Production of CAR T Cells for Treatment of Relapsed/Refractory Aggressive NHL and ALL
Therapeutic Plasma Exchange: A Cost‐Consequence Analysis Using Data From a Tertiary Care Hospital
Incidence and Risk Factors of Hypokalemia in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Collection
Thrombocytapheresis for Extreme Thrombocytosis: A 20‐Year Single‐Center Experience With Acute and Chronic Use in Myeloproliferative Neoplasms
Application of American Society for Apheresis Guideline Recommendations for Therapeutic Plasma Exchange: A Scoping Review of Published Literature
Red Blood Cell Exchange in a Resource‐Variable Setting: A Scoping Review of Two Decades of Indian Experience
From Vein to Vaccine: Monocentric Analysis of Monocyte Apheresis and Dendritic Cell Vaccine Manufacturing Procedures in the Pediatric Setting
Hematologic Response: The Missing Link in Evaluating Extracorporeal FLC Removal in Myeloma‐Associated AKI
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach From the Writing Committee of the American Society for Apheresis: The Tenth Special Issue
A Personalized, Rate‐of‐Rise ( ROR )–Driven Model to Optimize Red Cell Exchange Interval in Chronic Sickle Cell Management
An Abbreviated Course of Therapeutic Plasma Exchange Does Not Affect Platelet Count Recovery or Durability in Patients With Immune Thrombotic Thrombocytopenic Purpura Receiving Caplacizumab
Pediatric Therapeutic Plasma Exchange: Characterization of Practice, Epidemiology, and Safety Profile at a Children's Hospital in the United States
Issue Information
Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma
Optimal Timing of Therapeutic Plasma Exchange and Hepatic Encephalopathy Severity as Predictors of Clinical Outcome in Liver Failure: A Retrospective Observational Study
Correction to “Systematic Investigation of the Location of CD34 + Cells Within the Mononuclear Cell Layer of Hematopoietic Progenitor Cell Collections in Normal Donors”
Navigating Therapeutic Plasma Exchange in Critically Ill Children: A Retrospective Review of Indications, Timing, Outcomes, and Complications in a Developing Nation PICU
Plasmapheresis in Low Body Weight Infant With Acute Liver Failure
Extracorporeal Photopheresis ( ECP ) for Refractory Lichenoid Disorders: A Retrospective Analysis of Efficacy and Long‐Term Outcomes
Establishing a Safe and Effective Therapeutic Plasma Exchange Program in a Resource‐Constrained Transplant Center: A 6‐Year Nigerian Experience
An Annual Review of Important Apheresis Articles in 2025 From the American Society for Apheresis Attending Physician Subcommittee
Head‐To‐Head Intra Individual Comparison of Three Therapeutic Apheresis Modalities in Chronic Auto‐Immune Neuropathy: A Real‐World Experience
Low‐Volume Plasma Exchange Following Double Plasma Molecular Adsorption System in Acute‐On‐Chronic Liver Failure: A Plasma‐Sparing Strategy
Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use
Chronic Red Cell Exchange for the Management of Alpha Thalassemia Major Complicated by Iron Overload
Plerixafor Plus G‐ CSF Versus Etoposide Combined With Cyclophosphamide and G‐ CSF for Autologous Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Single Center Observational Propensity Score‐Matched Cohort Study
Correction to “Real‐World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis System”
Therapeutic Plasma Exchange in the Elderly: Rare Indications but Good Tolerability
Guidance for Documentation of Therapeutic Apheresis Interventions in the Medical Record: An American Society for Apheresis ( ASFA ) Practice Perspective
Volumes
2026 · 1242025 · 872024 · 672023 · 692022 · 802021 · 1162020 · 782019 · 712018 · 1032017 · 912016 · 672015 · 552014 · 452013 · 432012 · 522011 · 552010 · 402009 · 432008 · 262007 · 442006 · 422005 · 352004 · 342003 · 352002 · 362001 · 442000 · 311999 · 491998 · 511997 · 541996 · 541995 · 531994 · 561993 · 471992 · 561991 · 611990 · 191989 · 121988 · 411987 · 24
EUVIMED